Abstract: The present invention provides methods of treating pathologic conditions associated with intestinal ischemia. In the methods, patients at risk for or suffering from intestinal ischemia are treated with a heparin-binding epidermal growth factor product.
Type:
Application
Filed:
August 23, 2005
Publication date:
January 26, 2006
Applicant:
Children's Hospital, Inc., A Not-for-Profit Corporation